Madrigal Pharmaceuticals (NASDAQ:MDGL) Issues Quarterly Earnings Results, Misses Estimates By $1 32 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Lowered to $390 00 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) will be releasing its earnings data before the market opens on Tuesday, May 7th. Analysts expect Madrigal Pharmaceuticals to post earnings of ($6.06) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. Madrigal Pharmaceuticals (NASDAQ:MDGL – Get […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price objective […]
Bank of New York Mellon Corp boosted its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 4.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,786 shares of the biopharmaceutical company’s stock after acquiring […]